Ainos, Inc. operates as a dual-platform company combining artificial intelligence and biotechnology. The company's primary technology platform centers on SmellTech, which uses a smell language model to convert chemical scents into digital identifiers and machine-readable data. This AI Nose platform enables the digitization of olfactory information for diagnostic and analytical applications across multiple sectors including robotics, smart manufacturing, senior care, and women's health.
The company's therapeutic segment focuses on VELDONA, a low-dose oral interferon product in development targeting rare diseases, autoimmune conditions, and infectious diseases, with additional applications in animal health. Ainos operates with 44 full-time employees and maintains headquarters in San Diego, California. The company is a subsidiary of Taiwan Carbon Nano Technology Corporation. Originally incorporated in 1984 as Amarillo Biosciences, Inc., the company rebranded to Ainos, Inc. in May 2021 to reflect its expanded focus on AI and diagnostic technologies.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.56 | $-1.56 | — | |
| 2023 | — | — | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | $-0.01 | — | +0.0% | |
| 2012 | $-0.01 | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-07 | 0001493152-25-009568 | SEC ↗ |
| 2023-12-31 | 2024-03-08 | 0001654954-24-002897 | SEC ↗ |
| 2022-12-31 | 2023-04-03 | 0001654954-23-004157 | SEC ↗ |
| 2021-12-31 | 2022-03-21 | 0001654954-22-003463 | SEC ↗ |
| 2020-12-31 | 2021-03-30 | 0001654954-21-003517 | SEC ↗ |
| 2019-12-31 | 2020-03-30 | 0001437749-20-006575 | SEC ↗ |
| 2018-12-31 | 2019-04-16 | 0001014763-19-000004 | SEC ↗ |
| 2017-12-31 | 2018-04-18 | 0001014763-18-000004 | SEC ↗ |
| 2016-12-31 | 2017-04-17 | 0001014763-17-000003 | SEC ↗ |
| 2015-12-31 | 2016-03-30 | 0001014763-16-000029 | SEC ↗ |
| 2014-12-31 | 2015-04-13 | 0001014763-15-000006 | SEC ↗ |
| 2013-12-31 | 2014-04-15 | 0001014763-14-000008 | SEC ↗ |
| 2012-12-31 | 2013-04-01 | 0001014763-13-000002 | SEC ↗ |
| 2011-12-31 | 2012-04-19 | 0001014763-12-000006 | SEC ↗ |
| 2010-12-31 | 2011-04-12 | 0001014763-11-000005 | SEC ↗ |
| 2009-12-31 | 2010-04-01 | 0001014763-10-000001 | SEC ↗ |
| 2008-12-31 | 2009-03-31 | 0001014763-09-000008 | SEC ↗ |